000 | 02023cam a2200325 4500500 | ||
---|---|---|---|
005 | 20250121155314.0 | ||
041 | _afre | ||
042 | _adc | ||
100 | 1 | 0 |
_aDiaconeasa, Adriana _eauthor |
700 | 1 | 0 |
_a Voicu, Cristiana _eauthor |
700 | 1 | 0 |
_a Ivaniciuc, Mihaela _eauthor |
700 | 1 | 0 |
_a Miulescu, Raluca _eauthor |
700 | 1 | 0 |
_a Birsan, Cristina _eauthor |
700 | 1 | 0 |
_a Angué, Chloé _eauthor |
700 | 1 | 0 |
_a Chiriac, Anca _eauthor |
700 | 1 | 0 |
_a Schönlebe, Jacqueline _eauthor |
700 | 1 | 0 |
_a Wollina, Uwe _eauthor |
245 | 0 | 0 | _aCutaneous borreliosis in children - a challenging problem |
260 | _c2024. | ||
500 | _a2 | ||
520 | _aBorreliosis, also known as Lyme disease, is a vector-borne disease caused by different species of the Borrelia burgdorferi complex. It is frequent in Europe and Northern America. The major vectors are ixodoid ticks. Paediatric borreliosis is common and peaks in children between five to nine years. In Europe, the leading symptom of early infection is erythema migrans, in contrast to Northern America where arthritis is the dominating clinical finding. In this review, we focus on Europe, where cutaneous borreliosis is mainly caused by infection with B. afzelii. The cutaneous symptoms include erythema migrans, lymphocytoma, chronic atrophic dermatitis and juxta-articular nodules. In children, lymphocytoma is very common but chronic atrophic dermatitis is rare. Clinical symptoms, diagnosis, peculiarities of childhood disease and treatment are also reviewed. It is important to note that after haematogeneic spread, signs of infection may be non-specific, and this is a challenge for diagnosis. | ||
690 | _aborreliosis | ||
690 | _acutaneous findings | ||
690 | _achildren | ||
690 | _atreatment | ||
690 | _acourse | ||
690 | _aLyme disease | ||
786 | 0 | _nEuropean Journal of Dermatology | 34 | 1 | 2024-01-01 | p. 18-25 | 1167-1122 | |
856 | 4 | 1 | _uhttps://shs.cairn.info/revue-european-journal-of-dermatology-2024-1-page-18?lang=en&redirect-ssocas=7080 |
999 |
_c604410 _d604410 |